{"product_id":"9780470986349","title":"Stephens' Detection and Evaluation of Adverse Drug Reactions Principles and Practice","description":"\u003ch1\u003eStephens' Detection and Evaluation of Adverse Drug Reactions\u003c\/h1\u003e\u003ch2\u003ePrinciples and Practice\u003c\/h2\u003e\u003ch3\u003eJohn Talbot | Jeffrey K. Aronson\u003c\/h3\u003e\u003cdiv\u003e\u003cb\u003eMedical \/ Pharmacology\u003c\/b\u003e\u003c\/div\u003e\u003cbr\u003e\u003cdiv\u003eThe detection and evaluation of adverse drug reactions is crucial for understanding the safety of medicines and for preventing harm in patients. Not only is it necessary to detect new adverse drug reactions, but the principles and practice of pharmacovigilance apply to the surveillance of a wide range of medicinal products.  \u003cp\u003e\u003ci\u003eStephens' Detection and Evaluation of Adverse Drug Reactions\u003c\/i\u003e provides a comprehensive review of all aspects of adverse drug reactions throughout the life cycle of a medicine, from toxicology and clinical trials through to pharmacovigilance, risk management, and legal and regulatory requirements. It also covers the safety of biotherapeutics and vaccines and includes new chapters on pharmacogenetics, proactive risk management, societal considerations, and the safety of drugs used in oncology and herbal medicines.\u003c\/p\u003e \u003cp\u003eThis sixth edition of the classic text on drug safety is an authoritative reference text for all those who work in pharmacovigilance or have an interest in adverse drug reactions, whether in regulatory authorities, pharmaceutical companies, or academia.\u003c\/p\u003e \u003cp\u003ePraise for previous editions\u003c\/p\u003e \u003cp\u003e\"This book presents a comprehensive and wide-ranging overview of the science of pharmacovigilance. For those entering or already experienced in the pharmaceutical sciences, this is an essential work.” - from a review in \u003ci\u003eE-STREAMS\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\"...a key text in the area of pharmacovigilance...extensively referenced and well-written...a valuable resource...\" - from a review in \u003ci\u003eThe Pharmaceutical Journal\u003c\/i\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv\u003e  John Talbot, Senior Lecturer, University of Hertfordshire, UK. Formerly Director, Global Drug Safety, AstraZeneca R\u0026amp;D Charnwood, Loughborough, Leicestershire, UK  \u003cp\u003eJeffrey Aronson, Reader in Clinical Pharmacology, University of Oxford, Oxford, UK and President Emeritus of the British Pharmacological Society\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublication Date: \u003c\/td\u003e\n\u003ctd\u003e27 December 2011\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublisher: \u003c\/td\u003e\n\u003ctd\u003eWiley\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImprint: \u003c\/td\u003e\n\u003ctd\u003eWiley-Blackwell\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eISBN-13: \u003c\/td\u003e\n\u003ctd\u003e9780470986349\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFormat: \u003c\/td\u003e\n\u003ctd\u003eHardback\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePage Count: \u003c\/td\u003e\n\u003ctd\u003e752\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eWeight (oz): \u003c\/td\u003e\n\u003ctd\u003e38.72\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44310909649036,"sku":"9780470986349","price":372.56,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470986349.jpg?v=1780140790","url":"https:\/\/lateknightbooks.com\/products\/9780470986349","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}